SCHEMBL1363045

SCHEMBL1363045

O=C1OC(=O)C2C1C1C3C(=O)OC(=O)C3C21

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.48
GMNN O75496 1/20 0.48
PPM1B O75688 1/20 0.48
LMNA P02545 1/20 0.48
PPP1CC P36873 1/20 0.48
TFPI2 P48307 1/20 0.48
RAB9A P51151 1/20 0.48
PPP5C P53041 1/20 0.48
PPP1CA P62136 1/20 0.48
PMP22 Q01453 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
TP53 P04637 1/20 0.48
CYP2D6 P10635 1/20 0.48
NFKB1 P19838 1/20 0.48
THPO P40225 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12799496 1.00 KDM4E (0.48) KDM4EGMNNPPM1BLMNAPPP1CC
SCHEMBL13974478 0.89 KDM4E (0.46) KDM4EGMNNPPM1BLMNAPPP1CC
SCHEMBL14297394 0.89 KDM4E (0.46) KDM4EGMNNPPM1BLMNAPPP1CC
SCHEMBL13974347 0.89 KDM4E (0.46) KDM4EGMNNPPM1BLMNAPPP1CC
SCHEMBL13974476 0.89 KDM4E (0.46) KDM4EGMNNPPM1BLMNAPPP1CC
SCHEMBL910480 0.84 KDM4E (0.53) KDM4EGMNNPPM1BLMNAPPP1CC
SCHEMBL112827 0.84 KDM4E (0.53) KDM4EGMNNPPM1BLMNAPPP1CC
SCHEMBL19107418 0.84 KDM4E (0.53) KDM4EGMNNPPM1BLMNAPPP1CC
SCHEMBL21999910 0.84 KDM4E (0.53) KDM4EGMNNPPM1BLMNAPPP1CC
SCHEMBL16923832 0.84 KDM4E (0.53) KDM4EGMNNPPM1BLMNAPPP1CC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8067527-B2 Polyamic acid and polyimide NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-11-29 US disclosed
US-8067527-B2 Polyamic acid and polyimide NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-11-29 US disclosed
US-8067527-B2 Polyamic acid and polyimide NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-11-29 US disclosed
US-20090292103-A1 POLYAMIC ACID AND POLYIMIDE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2009-11-26 US disclosed
US-20090292103-A1 POLYAMIC ACID AND POLYIMIDE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2009-11-26 US disclosed
US-20090292103-A1 POLYAMIC ACID AND POLYIMIDE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090292103-A1 POLYAMIC ACID AND POLYIMIDE PARG, C9, F12 KDM4E 3174/4885GMNN 2995/4885PPM1B 4221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.